Summary
3M Company's 2023 10-K filing reveals a challenging year marked by significant litigation charges that resulted in a net loss for the period, contrasting with the prior year's net income. The company incurred substantial pre-tax charges totaling approximately $15.2 billion related to the Public Water Systems (PWS) Settlement and the Combat Arms Earplugs (CAE) Settlement. Operationally, 3M experienced a sales decline of 4.5% to $32.7 billion, with organic sales down 3.2%. All four business segments—Safety and Industrial, Transportation and Electronics, Health Care, and Consumer—saw declines in net sales. The company continues its strategic move to spin off its Health Care business, expected in the first half of 2024, which it believes will position both entities for future growth. Despite the operational challenges and legal headwinds, 3M maintained its commitment to returning capital to shareholders, with dividend increases and share repurchases. The company also provided an outlook for increased pension and postretirement expense in 2024.
Financial Highlights
55 data points| Revenue | $24.61B |
| Cost of Revenue | $14.98B |
| Gross Profit | $9.63B |
| R&D Expenses | $700.00M |
| SG&A Expenses | $19.20B |
| Operating Expenses | $35.30B |
| Operating Income | -$10.69B |
| Interest Expense | $942.00M |
| Net Income | -$7.00B |
| EPS (Basic) | $-12.63 |
| EPS (Diluted) | $-12.63 |
| Shares Outstanding (Basic) | 553.90M |
| Shares Outstanding (Diluted) | 553.90M |
Key Highlights
- 13M reported a net loss of $6.995 billion in 2023, primarily due to significant litigation charges related to the PWS Settlement ($10.5 billion pre-tax) and CAE Settlement ($4.3 billion pre-tax), totaling $15.2 billion in pre-tax charges.
- 2Total net sales decreased by 4.5% to $32.681 billion in 2023, with organic sales down 3.2%.
- 3All four business segments (Safety and Industrial, Transportation and Electronics, Health Care, Consumer) experienced sales declines.
- 4The planned spin-off of the Health Care business is anticipated to be completed in the first half of 2024.
- 5The company's financial health remains supported by a strong liquidity profile, with $6.0 billion in cash, cash equivalents, and marketable securities at year-end 2023, and a reduced net debt of $10.0 billion.
- 63M announced a 1% increase in its quarterly dividend to $1.51 per share for Q1 2024, demonstrating continued commitment to shareholder returns.
- 7The company is exiting all PFAS manufacturing by the end of 2025 and discontinuing the use of PFAS across its product portfolio by the end of 2025.